Actively Recruiting
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Led by Axsome Therapeutics, Inc. · Updated on 2026-02-09
620
Participants Needed
16
Research Sites
111 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study is a Phase 3, double-blind, placebo-controlled, randomized withdrawal study to assess the efficacy and safety of AXS-14 in the management of fibromyalgia.
CONDITIONS
Official Title
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Has a primary diagnosis of fibromyalgia based on the 2016 ACR diagnostic criteria.
- Male or female, 18 years of age or older.
- Provides written informed consent to participate in the study before conducting any study procedures.
You will not qualify if you...
- Previous participation in a clinical trial with reboxetine or esreboxetine or current treatment with reboxetine for any condition.
- Unable to comply with study procedures.
- Medically inappropriate for study participation according to the investigator.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 16 locations
1
Clinical Research Site
Little Rock, Arkansas, United States, 72211
Actively Recruiting
2
Clinical Research Site
Santa Ana, California, United States, 92705
Actively Recruiting
3
Clinical Research Site
Cromwell, Connecticut, United States, 06416
Actively Recruiting
4
Clinical Research Site
Jacksonville, Florida, United States, 32256
Actively Recruiting
5
Clinical Research Site
Orlando, Florida, United States, 32801
Actively Recruiting
6
Clinical Research Site
Tampa, Florida, United States, 33634
Actively Recruiting
7
Clinical Research Site
Atlanta, Georgia, United States, 30329
Actively Recruiting
8
Clinical Research Site
Overland Park, Kansas, United States, 66209
Actively Recruiting
9
Clinical Research Site
Louisville, Kentucky, United States, 40205
Actively Recruiting
10
Clinical Research Site
Prairieville, Louisiana, United States, 70769
Actively Recruiting
11
Clinical Research Site
Springfield, Missouri, United States, 65807
Actively Recruiting
12
Clinical Research Site
Town and Country, Missouri, United States, 63017
Actively Recruiting
13
Clinical Research Site
Tulsa, Oklahoma, United States, 74133
Actively Recruiting
14
Clinical Research Site
Charleston, South Carolina, United States, 29407
Actively Recruiting
15
Clinical Research Site
Memphis, Tennessee, United States, 38119
Actively Recruiting
16
Clinical Research Site
Prosper, Texas, United States, 75078
Actively Recruiting
Research Team
S
Study Director
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here